FloridaTaper
Evidence-based information on benzodiazepine tapering, withdrawal, and BIND
FloridaTaper publishes careful, evidence-informed writing on benzodiazepine tapering, withdrawal, and recovery — for patients, families, and clinicians.
Browse by topic
Latest articles
-
Long COVID and Protracted Benzodiazepine Withdrawal: Why the Clinical Picture Looks Nearly Identical
Long COVID and protracted benzodiazepine withdrawal produce symptom profiles that, viewed side by side without reference to their triggering events, are nearly indistinguishable. Fatigue, cognitive dysfunction, post-exertional worsening, orthostatic intolerance, autonomic instability,…
-
New Food Sensitivities During a Benzodiazepine Taper: When the Mast Cell Axis Drives the Reactions
A patient who tolerated a normal diet for decades may develop new, sometimes dramatic, reactions to foods during or after a benzodiazepine taper. Flushing, hives, heart palpitations, gut cramping, nasal congestion, sleep…
-
Dysautonomia After Long-Term Benzodiazepine Use: What Autonomic Function Testing Can and Cannot Show
Patients with autonomic symptoms after long-term benzodiazepine use — orthostatic intolerance, palpitations, temperature dysregulation, GI dysmotility, urinary dysfunction, sweating abnormalities — are sometimes referred for formal autonomic function testing (AFT) to objectively…
-
Histamine Intolerance During Benzodiazepine Withdrawal: Is a Low-Histamine Diet Worth Trying?
Histamine intolerance is one of the clinical frameworks patients encounter when investigating new food reactivity, flushing, headaches, and GI symptoms during or after a benzodiazepine taper. The question that typically follows is…
-
When a Neurologist Orders an MS Workup for a Patient With BIND: What the Differential Should Include
A patient with paresthesias, tremor, fatigue, cognitive dysfunction, and sensory disturbances arriving at a neurology clinic will often leave with an order for a multiple sclerosis (MS) workup. The reasoning is straightforward:…
-
Answering a BIND Patient’s Question About Full Recovery: What an Honest Clinical Answer Looks Like
“Will I ever fully recover” is one of the hardest questions a patient with benzodiazepine-induced neurological dysfunction (BIND) can ask, and one of the questions most likely to be answered poorly. Answered…
-
When Benzodiazepine-Induced Neurological Dysfunction (BIND) Is Misdiagnosed as Functional Neurological Disorder: Advocating for Accurate Documentation
When benzodiazepine-induced neurological dysfunction (BIND) is misdiagnosed as functional neurological disorder (FND), the record does not quietly correct itself. It travels with the patient, shaping how every subsequent clinician interprets new symptoms,…
-
Finding a Hyperbolic Tapering Specialist for a Benzodiazepine: What the Physiology Requires
Hyperbolic tapering is not a style preference. It is the dose-reduction strategy that reflects how benzodiazepine receptor occupancy actually changes as the dose decreases. The relationship between benzodiazepine dose and GABA-A receptor…
-
Low-Dose Naltrexone for BIND: Can an Immunomodulator Help With Benzo-Related Neuroinflammation?
Low-dose naltrexone (LDN) has drawn interest among patients and clinicians looking for tools to address the persistent symptoms of benzodiazepine-induced neurological dysfunction (BIND) — the syndrome of protracted neurological, cognitive, and autonomic…
-
Does Long-Term Klonopin Cause Emotional Blunting? What Patients Describe but Doctors Miss
Patients on long-term clonazepam — Klonopin — frequently describe a specific change that rarely appears in the chart. They feel less. Grief softens, joy softens, irritation softens, sexual response softens. The range…